Produced by: MOS Video Department
According to the media report, on May 3, 2022, Pfizer beat Wall Street’s first-quarter expectations, as their Q1 profit grew 61%, which was achieved with the help of the CCP virus vaccine sales.
Pfizer’s CCP virus vaccine, brand name Comirnaty, has been Pfizer’s top seller for about a year, bringing in more than $13 billion in sales in the quarter.
As of May 5, 2022, more than 11.5 billion doses of CCP virus vaccines have been administered across 184 countries since Dec 2020. Pfizer/BioNTech has the most CCP virus vaccine doses administered worldwide.
According to a data report, in European Union, from Dec 27, 2020, to May 4, 2022, the top 4 manufacturers of the CCP virus vaccine doses administered are:
Pfizer/BioNTech : 610.15 million
Moderna: 147.04 million
AstraZeneca: 67.53 million
Johnson & Johnson: 18.68 million
In the U.S., by May 4, 2022, the top 3 manufacturers of the CCP virus vaccine doses administered are:
Pfizer/BioNTech : 340.6 million
Moderna: 217.5million
Johnson & Johnson: 18.7 million
Recently, Steve Bannon’s Warroom disclosed the alignment between Pfizer/BioNTech and the Chinese Communist Party (CCP); in the episode of Apr 27, it said,
“2009: Pfizer opened research and development hubs in three Chinese cities; one of them was Wuhan.
2020: Pfizer partnered with BioNTech right as the pandemic was rolling out to acquire their mRNA vaccine technology to produce the mRNA vaccines.
March 2020: BioNTech united with Fosun pharmaceuticals out of Shanghai, China. Fosun injected $100 million into its joint venture. BioNTech agreed to provide the patent technology, and Fosun agreed to build the factories.
2021 SEC Filing Statement: There was a completed 100% tech transfer from BioNTech to Communist China (no mention of Fosun Pharmaceuticals).”
Posted by: Yuki jiang
For more information, follow us